InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,461.18
(
0.19%
)
Post# of 14825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Yourstomine

Send PM Follow Ignore
Followers 10
Posts 689
Boards Moderated 0
Alias Born 09/26/2013

Yourstomine

Re: None

Tuesday, 04/15/2014 12:44:31 AM

Tuesday, April 15, 2014 12:44:31 AM

Post# of 14825
********COMING SOON********
Partial information below about the "TO COMPLETE" FDA approval of (A-2)

INVESTMENT AGREEMENT

THIS INVESTMENT AGREEMENT is made as of January 9th, 2014 by and between Calypte Biomedical Corporation, a Delaware corporation (the “Company”) , and DP TZUAN (HK) LIMITED (the “Purchaser”).

RECITALS:


A.

The Company requires additional financing to complete the FDA approval procedures for the new product “AWARE-2.”

See complete 8-K issued 01-15-2014
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up